Stay updated on BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page.
Latest updates to the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe website has been updated to version v2.10.3, with the notable removal of FDA Safety Alerts and Recalls from the previous version v2.10.2.SummaryDifference0.4%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2.SummaryDifference0.1%
- Check35 days agoNo Change Detected
- Check49 days agoChange DetectedThe study has expanded to 63 locations and has been updated to revision v2.10.0, replacing the previous revision v2.9.7.SummaryDifference0.5%
- Check50 days agoChange DetectedA new Investigator Inquiry Form has been added to the website.SummaryDifference0.2%
- Check57 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check70 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
Stay in the know with updates to BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986205 Combo with Nivolumab in Melanoma Clinical Trial page.